Rowley Law PLLC is investigating potential securities law violations by Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) and its board of directors concerning the proposed acquisition of the company by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). Stockholders will receive $18.00 for each share of Portola Pharmaceuticals stock that they hold. The transaction is valued at approximately $1.4 billion […]

Rowley Law PLLC is investigating potential securities law violations by Stemline Therapeutics Inc. (NASDAQ: STML) and its board of directors concerning the proposed acquisition of the company by Menarini Group. Stockholders will receive $11.50 and one contingent value right of $1.00 for each share of Stemline Therapeutics stock that they hold. The transaction is valued […]

Rowley Law PLLC is investigating potential securities law violations by resTORbio, Inc. (NASDAQ: TORC) and its board of directors concerning the proposed acquisition of the company by Adicet Bio, Inc. Adicet stockholders will receive newly issued shares of resTORbio common stock, leaving Adicet stockholders to own approximately 75% of the combined company. The transaction is […]